Skinbetter Science was founded in 2016 by three pharmaceutical professionals, according to the press release. The brand is primarily dispensed in medical offices like dermatology, plastic surgery and medical aesthetics practices.
According to the L’Oréal press release, the brand focuses on innovation in active ingredients for anti-aging, moisturizing, cleansing, exfoliating, skin peeling and sun protection.
“Skinbetter Science is a perfect complement to the Active Cosmetics Division’s brand portfolio,” Myriam Cohen-Welgryn, Worldwide President of L’Oréal’s Active Cosmetics Division, said in the release. “It will contribute greatly to the L’Oréal Active Cosmetics Division’s long-standing mission to pioneer health and beauty with advanced science-based skincare innovations.”
She also said L’Oréal sees international potential in the skincare brand.
The release also said the brand will continue to be run by the Arizona-based leadership team under the Active Cosmetics Division of L’Oréal USA.
Click through to learn more about L’Oréal’s place in the market today.
L'Oréal has launched two new technologies for mass-market consumers and stylists, developed to circumvent hair coloring problems “only technology could solve.”
The company announced the Colorsonic and Coloright technologies on Monday, ahead of CES 2022. Both products, Colorsonic for consumers and Coloright for hairstylists, address ease-of-use with color application.
Head of the L'Oréal Global Technology Incubator Guive Balooch said they’re particularly excited about making these innovations in the hair coloring space, which the company launched more than a century ago.
“What we've seen in the past 100 years is lots of innovation in the types of formulas and colors to get to the right chemistry,” Balooch told cosmetics design. “But the way of actually applying it on the hair, both at home and in the salon, hasn't really changed at all.”
International beauty major L’Oréal has reported a significant rise in full-year 2021 sales and net profit globally, with Latin America and North Asia performing particularly well and business in its Luxe and Active Cosmetics divisions leading the surge.
L’Oréal generated worldwide sales of €9.09bn in the fourth quarter (Q4) of 2021, up 15.4% on the previous year. Within this, L’Oréal’s active cosmetics saw the biggest sales spike, up 28.4% in Q4, followed by professional products (up 18.5%), L’Oréal luxe (up 16.5%) and consumer products (up 10%). Regionally, North America reported the most significant Q4 sales growth, up 25.1% on the previous year.
For the full year of 2021, sales sat at €32.2bn, up 15.3%, with net profit after controlling interests tallying up at €4.59bn, up 29% on the previous year. In sales terms, Latin America reported the biggest annual spike at 20.6%, followed by North Asia (18.6%), North America (18.1%), Europe (10.7%) and South Asia Pacific, Middle East and North Africa [SAPMENA] (10%).
“2021 was a historic year for L’Oréal,” said Nicolas Hieronimus, CEO at L’Oréal. Total group growth was double that of the worldwide beauty market, Hieronimus said, and the company gained market share in all zones, business divisions and product categories.
International beauty major L’Oréal has developed a method to identify the molecular signature of a person’s scalp in a common alopecic state, enabling prognosis and diagnosis, along with the development of efficacious cosmetic treatments for such hair loss.
Writing in its international patent, L’Oréal said it had developed a method for the in vitro prognosis and/or diagnosis of a “common alopecic state of the scalp” by measuring the expression level of very specific genes* involved in the intercellular junctions of the scalp and/or hair follicle. It also outlined an in vitro method to evaluate the efficacy of treating a common alopecic state, including testing cosmetic treatments like hair lotions, gels, shampoos and conditioners made using gene modulators and certain active compounds.
*Genes identified by L’Oréal: CDH1, ACTB, ACTBL2, TUBB, TUBB2A, GSN, MY03B, MY05B, MY06, DSG2, DSG3, DSG4, DSC2, GJB2, GJA1, GJB6, GJA3, TJP2, CLDN8, CLDN10, CLDN19, and optionally CTNNB1 and CTNND2
L’Oréal said the prognosis, diagnosis and treatment methods specifically related to common alopecia caused by disruptions of the hair cycle, as opposed to immune alopecias like alopecia areata or spot baldness, alopecia universalis and alopecia totalis. Assessment and treatment could therefore be used for the likes of androgenetic alopecia, traction alopecia, female pattern hair loss, cicatricial alopecia, chemotherapy-induced or radiotherapy-induced alopecia, telogen effluvium, stress-related alopecia, seasonal alopecia, age-related alopecia and micro-inflammatory alopecia.
Beauty multinational L’Oréal says there is huge room for growth across its SAPMENA region with emerging demographics and online selling channels poised to take off.
On January 13, Shopee, an e-commerce platform that operates in South East Asia and Taiwan, announced that L’Oréal’s consumer products division (CPD), which consists of brands such as L’Oréal Paris, Garnier and Maybelline, achieved at least U$100m in goods merchandise value (GMV).
L’Oréal was the only beauty brand that achieved this alongside a slew of technology brands, namely Samsung, Oppo, Xiaomi, and realme.
Speaking exclusively to CosmeticsDesign-Asia, Manashi Guha, L’Oréal CPD general manager of SAPMENA region, said this achievement did not come as a surprise for the French beauty giant.
Innovation in cosmetic ingredients targeting the skin microbiome is surging, but the ultimate dream is to be able to incorporate beneficial live bacteria into formulations, says a principal scientist at L’Oréal Research & Innovation.
Interest in the skin microbiome – an ecosystem made up of fungi, bacteria and viruses – had soared in recent years, driven by expanding scientific research and knowledge, new product development and consumer interest in skin health. But as the beauty and personal care industry continued its efforts in research, innovation and education in this field, where exactly were the biggest target opportunities? And what sort of goals did beauty majors like L’Oréal have in mind?
‘The skin is here to protect us’
Dr Magali Moreau, principal scientist and head of the microbiome laboratory group at L’Oréal Research & Innovation, presented at this year’s IFSCC Congress in London on just exactly the group believed the skin microbiome could be harnessed.
“Today, we have to consider the microbiome when we consider applying anything on our skin, regardless of our intention, because it is part and parcel of the skin barrier function,” Moreau told attendees during her keynote presentation at the Congress.
